MEDICAL TOURISM BUSINESS PLAN

I. Executive Summary

Company Description

GlobalBridge Health (name reflects a verified bridge between U.S. patients and accredited international providers) is a U.S.-based medical tourism marketplace operating in the healthcare services sector. We match American patients with accredited hospitals and specialists abroad via a technology platform and a dedicated patient-advocacy team. Core offerings include provider vetting, teleconsultations, case coordination, travel and lodging logistics, and transparent bundled pricing. We earn revenue through commission on transactions and recurring subscriptions for employers and brokers. One-liner: a trusted, accredited bridge that simplifies safe, lower-cost global care.

We run a central office with a lean team focused on engineering and patient advocacy, and we operate provider quality audits, data-driven pricing, and a CRM-driven care-coordination workflow to deliver outcomes and reduce total cost of care. We target U.S. adults 35–64 facing high elective procedure costs, self-insured employers, and brokers seeking out-of-network savings. Short-term goals: launch in 2026 and validate the model with an initial patient cohort and paying subscribers. Long-term goal: achieve Year 5 EBITDA of $14,787,000. One-liner: validated marketplace scaling to sustainable, profitable medical tourism.

Problem

Millions of Americans face prohibitively high costs for essential and elective procedures, long specialist wait times, and limited access to specific treatments, so many delay or forgo care. Navigating international healthcare options is complex and overwhelming for the average consumer, and there is no centralized, reliable system that vets overseas provider quality or standardizes safety ratings.

The market lacks a trusted, transparent bridge to accredited international providers; this gap creates decision paralysis, exposes patients to unvetted risk, reduces outcome transparency, and drives higher out-of-pocket burdens—forcing a new solution that improves access, lowers cost, and protects patient safety.

Solution

Millions of U.S. residents face high prices or long waits for elective care; uninsured and underinsured patients lack a safe, affordable path to international alternatives where typical elective surgeries average $12,000 in savings.

We operate an end-to-end online marketplace connecting U.S. patients with credentialed international hospitals: compare transparent procedure pricing, book care and pay securely, arrange travel and logistics, centralize medical records, and charge a variable commission starting at 12.0% of order value in 2026.

Mission Statement

We democratize access to high-quality, affordable healthcare by empowering Americans to confidently seek medical treatment globally, ensuring safety and transparency at every step. We bridge rising U.S. healthcare costs and world-class international providers to deliver a seamless, secure, and value-driven patient experience. We strive to be the world’s most trusted marketplace for medical travel and to uphold patient safety, clear pricing, and provider excellence. Financial goal: deliver a 33.74% Return on Equity to our stakeholders.

Key Success Factors

These factors drive profitability, scalability, and investor returns for the medical tourism platform.

• Rigorous provider vetting ensures only top-quality international clinics are listed.
• Scalable technology platform supports high transaction volumes with minimal incremental cost.
• Digital marketing efficiency sustains patient acquisition at a $400 CAC.
• Strategic partnerships with accreditation bodies and travel providers enhance value and referrals.
• Capital efficiency demonstrated by a 9-month payback and a 25% target IRR.

Financial Summary

Key financials show rapid breakeven, positive near-term EBITDA, and a targeted cumulative five-year EBITDA of $31,666,000.

Financial requirements: Initial Capex $227,000 for platform and office (early 2026); minimum cash required $845,000 (Feb-26). Marketing budgets scale from $350,000 in 2026 to $1,850,000 in 2030. Anticipated return: breakeven Jan-26, 9-month payback, IRR 0.25%, ROE 33.74%.

Outlook: strong EBITDA growth to $14,787,000 by 2030 and cumulative five-year EBITDA of $31,666,000.

Funding Requirements

We require $845,000 in initial capital to fund platform build, office setup, first-year marketing, and launch working capital to reach the February 2026 minimum cash milestone.

Financial snapshot: Year 1 EBITDA $486,000 growing to $14,787,000 by Year 5; initial CapEx $227,000; breakeven expected January 2026 with a 9-month payback; marketing spend scales from $350,000 in 2026 to $1,850,000 in 2030; cumulative 5-year EBITDA target $31,666,000.